Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/02/2012US20120196877 Compositions of 5-ht3 antagonists and dopamine d2 antagonists for treatment of dopamine-associated chronic conditions
08/02/2012US20120196876 (9e)-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza-tetracyclo[18.3.1.1(2.5).1(14,18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt
08/02/2012US20120196875 Pharmaceutical compositions for treatment of respiratory and inflammatory diseases
08/02/2012US20120196874 Stilbene analogs and methods of treating cancer
08/02/2012US20120196873 Stabilization of amorphous drugs using sponge-like carrier matrices
08/02/2012US20120196872 New 5-alkynyl-pyridines
08/02/2012US20120196871 Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors
08/02/2012US20120196870 Combination therapy and cancer
08/02/2012US20120196869 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
08/02/2012US20120196868 Therapeutic compositions and methods
08/02/2012US20120196867 Composition comprising a pde4 inhibitor and a pde5 inhibitor
08/02/2012US20120196866 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
08/02/2012US20120196865 Acyl Guanidine Derivatives Modulating The Hedgehog Protein Signaling Pathway
08/02/2012US20120196864 Prophylactic or therapeutic agent for cancer
08/02/2012US20120196863 1,4 oxazines as bace1 and/or bace2 inhibitors
08/02/2012US20120196862 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012US20120196861 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012US20120196860 Triazine derivatives and their therapeutical applications
08/02/2012US20120196859 Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase
08/02/2012US20120196858 Method of promoting apoptosis and inhibiting metastasis
08/02/2012US20120196857 Modulators of Muscarinic Receptors
08/02/2012US20120196856 Aryl aminopyridine pde10 inhibitors
08/02/2012US20120196855 Oxygen linked pyrimidine derivatives
08/02/2012US20120196854 Pharmaceutical composition comprising aromatic heterocyclic compound
08/02/2012US20120196853 Novel Quinoline-Hepcidine Antagonists
08/02/2012US20120196852 Inhibitors of methionine aminopeptidases and methods of treating disorders
08/02/2012US20120196851 Wnt pathway antagonists
08/02/2012US20120196850 ASSOCIATION OF A SINUS NODE If CURRENT INHIBITOR AND AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
08/02/2012US20120196849 Compounds and compositions as hedgehog pathway modulators
08/02/2012US20120196848 Thienooxazepine derivative
08/02/2012US20120196847 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors
08/02/2012US20120196846 Anti-rsv compounds
08/02/2012US20120196845 Quinolinone-pyrazolone m1 receptor positive allosteric modulators
08/02/2012US20120196844 Compounds and compositions as modulators of gpr119 activity
08/02/2012US20120196843 Compositions containing topical-active agents and pentyleneglycol
08/02/2012US20120196842 Certain chemical entities, compositions, and methods
08/02/2012US20120196840 Compositions and Methods for Treating, Reducing, Ameliorating, or Preventing Infections
08/02/2012US20120196839 Compounds as lysophosphatidic acid receptor antagonists
08/02/2012US20120196838 Compounds for inflammation and immune-related uses
08/02/2012US20120196837 Method of treating frailty
08/02/2012US20120196835 Enzyme inhibiting compounds and methods
08/02/2012US20120196834 Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs
08/02/2012US20120196833 Phosphorus containing quinazoline compounds and methods of use
08/02/2012US20120196832 Substituted polyalkoxysiloxane compositions and methods of use
08/02/2012US20120196831 COMPOSITION FOR TREATING AND PREVENTING OBESITY INCLUDING HIGH WATER-SOLUBLE 2-HYDROXYPROPYL-betaCYCLODEXTRIN AS EFFECTIVE COMPONENT
08/02/2012US20120196830 Kits and improved compositions for treating lower urinary tract disorders
08/02/2012US20120196829 Method of using beta-hydroxy-beta-methylbutyrate for the prevention and treatment of disease conditions
08/02/2012US20120196828 Sensitization of cancer cells to treatment
08/02/2012US20120196827 Methylation markers for early detection and prognosis of colon cancers
08/02/2012US20120196826 Methods for transdifferentiation of body tissues
08/02/2012US20120196825 Compositions and methods for modulating the immune system
08/02/2012US20120196824 Therapeutic agent for cerebral infarction
08/02/2012US20120196823 Pharmaceutical compositions of cytidine analogs and methods of use thereof
08/02/2012US20120196822 Diyne Compositions
08/02/2012US20120196821 Method and formulation for the control of parasites
08/02/2012US20120196819 Animal treatments
08/02/2012US20120196818 Method for preparing polyphenol extracts from spinach leaves
08/02/2012US20120196817 Method for enhancing nutrient absorption with astragalosides
08/02/2012US20120196816 Method for enhancing nutrient absorption with astragalosides
08/02/2012US20120196815 Withanolide Isolated from Physalis longifolia and Analogs and Methods of Use Thereof
08/02/2012US20120196814 (R)-1-(4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLO[2,1-f][1,2,4]TRIAZIN-6-YLOXY)PROPAN-2-OL METABOLITES
08/02/2012US20120196813 Glycoside derivative and uses thereof
08/02/2012US20120196812 Pharmaceutical composition, methods for treating and uses thereof
08/02/2012US20120196811 Veterinary pharmaceutical composition and method (alternatives) for the prophylaxis and treatment of diseases of the gastrointestinal tract and intoxications of diverse etiology in animals
08/02/2012US20120196801 Wound-healing, anti-ambustial, regenerating, and anti-viral pharmaceutical formula for local administration
08/02/2012US20120196791 Combination therapies using antibacterial aminoglycoside compounds
08/02/2012US20120196746 Branched copolymer/anthranilic diamide compositions for propagule coating
08/02/2012US20120196301 Use of binding partners for 5-ht5 receptors for the treatment of neurodegenerative and neuropsychiatric disorders
08/02/2012US20120196057 Combination of vitamin d and 25-hydroxyvitamin d 3
08/02/2012US20120195988 Therapeutic Uses for Plants of the Capsicum Genus
08/02/2012US20120195987 Substances for reducing occurrence of major cardiac events comprising epa or derivatives thereof, optionally, dha or derivatives thereof and monacolin k
08/02/2012US20120195985 Glycine transporter-1 inhibitors
08/02/2012US20120195984 Diagnosis and treatment of the prodromal schizophrenic state
08/02/2012US20120195981 Micronutrient supplement with calcium, vitamin d or calcium & vitamin d combination for premenstrual syndrome, postpartum depression, depression and panic attacks
08/02/2012US20120195979 Treatment composition for recreational water
08/02/2012US20120195976 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation
08/02/2012US20120195968 Controlled-release melatonin compositions and related methods
08/02/2012US20120195967 Silk-based drug delivery system
08/02/2012US20120195966 Oral dosage form for modified release comprising a jak3 inhibitor
08/02/2012US20120195965 Solid dosage form comprising a fibrate
08/02/2012US20120195964 Phosphate-binding magnesium salts and uses thereof
08/02/2012US20120195963 Highly purified ethyl epa and other epa derivatives
08/02/2012US20120195961 Use of Spinosyns and Spinosyn Compositions Against Disease Caused By Protozoans, Viral Infections and Cancer
08/02/2012US20120195960 Post-exposure therapy of influenza a infections
08/02/2012US20120195958 Implantable devices
08/02/2012US20120195957 Novel nanoparticle formulations for skin delivery
08/02/2012US20120195956 Adhesive skin patch
08/02/2012US20120195955 Sublingual films
08/02/2012US20120195951 Therapeutic Inhibitor of Vascular Smooth Muscle Cells
08/02/2012US20120195947 Protein nanocarriers for topical delivery
08/02/2012US20120195942 Dosage forms of active ingredients containing hydroxystilbene for treating menopausal complaints
08/02/2012US20120195936 Rna with a combination of unmodified and modified nucleotides for protein expression
08/02/2012US20120195934 Polymeric gel delivery system for pharmaceuticals
08/02/2012US20120195933 Pharmaceutical compositions comprising tasocitinib
08/02/2012US20120195932 Geodate delivery vehicles
08/02/2012US20120195930 Novel pyridine derivatives
08/02/2012US20120195929 Compounds that modulate autoimmunity and methods of using the same
08/02/2012US20120195928 Vaccines and methods for using the same
08/02/2012US20120195923 Use of skin care compositions comprising laminariacea extract for treatment of skin aging signs
08/02/2012US20120195920 Staphylococcus aureus div1b for use as vaccine
1 ... 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 ... 7860